Abstract
Rosette formation of human lymphocytes with untreated sheep erythrocytes (E) or sheep erythrocytes treated with antibody and complement (EAC) may be employed as a marker of T and B lymphocytes. Cells from 16 patients with leukemia and from 18 with lymphoma were compared with normal lymphocytes in their ability to form E and EAC rosettes. The results were compared with the <i>in vitro </i>responses to PHA and MLR. A correlation was observed between the impaired responses to PHA and MLR and diminished percentages of cells having receptors for E or both E and EAC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International archives of allergy and applied immunology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
